Почетна › Рак на ендометриумот › Вирџинија › Arlington
Клинички испитувања за Рак на ендометриумот во Arlington, VA
39 студии за Рак на ендометриумот бараат учесници на локации во и околу Arlington (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Се регрутираФаза 2
- Inova Fairfax Hospital, Falls Church · на 4 милји
- Inova Schar Cancer Institute, Fairfax · на 11 милји
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- Inova Schar Cancer Institute, Fairfax · на 11 милји
- NEXT Virginia, Fairfax · на 11 милји
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Се регрутираФаза 1
- Site 04, Fairfax · на 11 милји
Study of AVZO-021 in Patients With Advanced Solid Tumors
Се регрутираФаза 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · на 11 милји
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Се регрутираФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 милји
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Се регрутираФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Се регрутираФаза 3
- Inova Schar Cancer Institute ( Site 6003), Fairfax · на 11 милји
- Virginia Cancer Specialists (VCS) ( Site 8008), Fairfax · на 11 милји
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Се регрутираФаза 1/2
- NEXT Oncology, Fairfax · на 11 милји
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Се регрутираФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 милји
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
Се регрутираФаза 1
- NEXT Oncology, Fairfax · на 11 милји
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Се регрутираФаза 3
- Research Site, Fairfax · на 11 милји
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Се регрутираФаза 1
- Inova Schar Cancer Institute, Falls Church · на 4 милји
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Се регрутираФаза 1/2
- Research Site, Fairfax · на 11 милји
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Се регрутираФаза 1
- Normunity Investigational Site, Fairfax · на 11 милји
A Study of PHST001 in Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Oncology - Virginia, Fairfax · на 11 милји
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · на 11 милји
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Се регрутираФаза 1/2
- USOR Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Се регрутираФаза 3
- Research Site, Falls Church · на 4 милји
- Research Site, Fairfax · на 11 милји
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Се регрутираФаза 2
- 522, Fairfax · на 11 милји
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · на 11 милји
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Се регрутираФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 милји
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- NEXT, Fairfax · на 11 милји
A Study of LY4175408 in Participants With Advanced Cancer
Се регрутираФаза 1
- NEXT Virginia, Fairfax · на 11 милји
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Се регрутираФаза 1
- NEXT Texas LLC - Virginia, Fairfax · на 11 милји
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Се регрутираФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Се регрутираФаза 1
- Dren Investigational Site, Fairfax · на 11 милји
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Се регрутираФаза 2
- Virginia Cancer Specialists, P.C., Fairfax · на 11 милји
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Се регрутираФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 милји
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Се регрутираФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 милји
Испитувања за Рак на ендометриумот во други градови
- Houston, TX68 студии
- New York City, NY52 студии
- Boston, MA50 студии
- Nashville, TN38 студии
- Los Angeles, CA34 студии
- St. Louis, MO29 студии
- Philadelphia, PA28 студии
- San Antonio, TX27 студии
- Chicago, IL25 студии
- Queens, NY25 студии
- Columbus, OH25 студии
- Oklahoma City, OK25 студии
Други студии во Arlington
- Рак на бели дробови со не-мали клетки104 студии
- Метастатски карцином53 студии
- Колоректален карцином52 студии
- Рак (сите типови)48 студии
- Рак на дојка46 студии
- Карцином на јајниците46 студии
- Рак на бели дробови41 студија
- Карцином на панкреасот33 студии
- Сквамозноклеточен карцином на глава и врат26 студии
- Малоклеточен рак на бели дробови23 студии
- Трипл негативен рак на дојка20 студии
- Рак на стомакот20 студии
Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.